Umbilical cord

Global Cord Blood Banking Services Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 13, 2022

Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use.

Key Points: 
  • Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use.
  • Key Questions Answered in This Report:
    How has the global cord blood banking services market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cord blood banking services market?
  • What is the structure of the global cord blood banking services market and who are the key players?

Infant with Rare Condition Receives Life-Saving At-Birth Procedure at Hassenfeld Children's Hospital at NYU Langone

Retrieved on: 
Thursday, September 22, 2022

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Aydin Idris Martin, an infant with an extremely rare and serious birth defect, was saved at birth when a multidisciplinary team at Hassenfeld Children's Hospital at NYU Langone performed a highly specialized procedure.

Key Points: 
  • The condition, the causes of which remain unknown, comes with a 100 percent mortality rate unless an intervention is performed.
  • The condition would make breathing impossible and fatal for the baby after a traditional delivery."
  • You need to have a medical center that offers all these subspecialists in one setting and that's Hassenfeld Children's Hospital at NYU Langone."
  • "The team at Hassenfeld Children's Hospital is now family to us," says Aydin's mother Yadi.

Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022

Retrieved on: 
Wednesday, September 14, 2022

TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ -- We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide. This year's official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking cord blood research and novel cell therapies in the potential treatment of HIV, autism, cerebral palsy and more.

Key Points: 
  • Learn how cord blood is used to treat 80+ life-threatening diseases including many blood cancers and holds tremendous potential in the treatment of HIV, autism and cerebral palsy.
  • TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ -- We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide.
  • This year's official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking cord blood research and novel cell therapies in the potential treatment of HIV, autism, cerebral palsy and more.
  • Cord blood is the blood left in the umbilical cord and placenta following the birth of a child.

RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of Next-Generation Cell Therapy for Patients with Duchenne Muscular Dystrophy

Retrieved on: 
Tuesday, September 6, 2022

CORONA, Calif. and ASBURY PARK, N.J., Sept. 6, 2022 /PRNewswire-PRWeb/ -- RESTEM, a pioneering, next-generation, clinical-stage cell therapy company focused on harnessing the unique power of cell therapy and JAR of Hope, a 501(3)(C) non-profit foundation dedicated to ongoing research efforts to find a cure for Duchenne Muscular Dystrophy (DMD), today announced a strategic collaboration and launch of a landmark clinical trial to evaluate RESTEM's novel, umbilical cord lining stem cell (ULSC) therapy for the treatment of Duchenne Muscular Dystrophy.

Key Points: 
  • If the Phase I trial is successful, a Phase II trial is expected to follow, which will assess effectiveness of ULSC therapy in a larger number of DMD patients.
  • Our goal is to one day see the words Duchenne muscular dystrophy only in history book, just like polio.
  • "We are honored to have the generous financial support from JAR of Hope to bring this potentially game-changing therapy to DMD patients as quickly as possible."
  • Jamesy is the inspiration behind JAR of Hope and Jim is committed to all of the children with DMD around the world.

Therapeutic Solutions International Provides Correction Re Prior Release

Retrieved on: 
Wednesday, March 30, 2022

Therapeutic Solutions International announced today the correction of a statement made in a press release dated March 25, 2022, that said, among other things, that: As part of the trial organization, the Principal Investigator has been changed to Dr. James Veltmeyer and Therapeutic Solutions International, Inc as the Sponsor.

Key Points: 
  • Therapeutic Solutions International announced today the correction of a statement made in a press release dated March 25, 2022, that said, among other things, that: As part of the trial organization, the Principal Investigator has been changed to Dr. James Veltmeyer and Therapeutic Solutions International, Inc as the Sponsor.
  • In addition to clarify, JadiCell adult stem cells are umbilical cord derived mesenchymal like stromal cells also referred to as adult stem cells.1-5
    Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.
  • Slavin S, Kurkalli BG, Karussis D: The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
  • Hafizi, M., et al., Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications.

Global Colonoscopes Markets, 2021-2028 - Artificial Intelligence in Colonoscopy, Disposable Colonoscopes, & Growing Awareness about Colon Cancer - ResearchAndMarkets.com

Retrieved on: 
Monday, February 7, 2022

Factors such as increase in the prevalence of colorectal cancer and continuous technological advancements in colonoscopy devices boost the market growth.

Key Points: 
  • Factors such as increase in the prevalence of colorectal cancer and continuous technological advancements in colonoscopy devices boost the market growth.
  • However, the availability of alternative diagnostic tests for rectal diseases hampers the growth of the colonoscopes market.
  • Colonoscopes are used to remove foreign bodies, excise tumors or colorectal polyps (polypectomy), and control bleeding.
  • Colonoscopes have several open channels for suction, water, and air supply as well as for the insertion of accessory instruments and cannulas.

City of Hope and CytoImmune announce study demonstrating novel off-the-shelf chimeric antigen receptor (CAR) natural killer (NK) cell-based therapy against pancreatic cancer

Retrieved on: 
Tuesday, January 18, 2022

Secondly, it is an immunologic approach, using human natural killer cells, which are specifically engineered to attack the patient's cancer.

Key Points: 
  • Secondly, it is an immunologic approach, using human natural killer cells, which are specifically engineered to attack the patient's cancer.
  • He also is senior consultant-clinical investigator at City of Hope and is one of the nations leading authorities on the treatment and care of pancreatic cancer patients.
  • Pancreatic cancer is the third leading cause of cancer-related death in the United States with a five-year survival rate of approximately 10%.
  • Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy .

ESSENT BIOLOGICS AND AMNION FOUNDATION PARTNER TO PROVIDE GERMINAL-ORIGIN CELLS TO FURTHER DRUG DISCOVERY AND REGENERATIVE MEDICINE RESEARCH

Retrieved on: 
Tuesday, December 14, 2021

This distribution agreement marks the first time that several unique cell types - cytotrophoblasts, Hofbauer cells, and placental stem/stromal cells - have been made commercially available worldwide for use in regenerative medicine, toxicology, and drug development.

Key Points: 
  • This distribution agreement marks the first time that several unique cell types - cytotrophoblasts, Hofbauer cells, and placental stem/stromal cells - have been made commercially available worldwide for use in regenerative medicine, toxicology, and drug development.
  • "We are thrilled to work with the team at Essent to get our unique cells in the hands of leading researchers discovering and developing new in vitro models and regenerative medicine products."
  • The PSCs, backed by over two decades of peer-reviewed scientific publications, are now available to support research in regenerative medicine.
  • The nonprofit biotechnology company provides low-passaged primary cells, research tissue and scaffold materials to advance regenerative medicine research from benchtop to bedside.

Statement from the Chief Public Health Officer of Canada - Importance of COVID-19 Vaccination in Pregnant, Recently Pregnant and Breastfeeding People

Retrieved on: 
Friday, November 26, 2021

One key group that appears to have lower uptake of COVID-19 vaccines is people who are pregnant.

Key Points: 
  • One key group that appears to have lower uptake of COVID-19 vaccines is people who are pregnant.
  • This is particularly concerning because there is growing evidence that pregnant people and their babies are at increased risk of severe illness due to COVID-19.
  • Research shows that vaccination with mRNA COVID-19 vaccines during pregnancy triggers the development of antibodies against the virus.
  • Recently, rumours and disinformation have been spreading on social media regarding increased risk of stillbirths in Canada with vaccination.

BioBridge Global continues history of innovation with umbilical cord collection and processing under cGMP standards for further manufacture

Retrieved on: 
Thursday, November 18, 2021

BioBridge Global hasbeen collecting, testing, and delivering material under cGMP and/or cGTP for clinical use for more than 45 years.

Key Points: 
  • BioBridge Global hasbeen collecting, testing, and delivering material under cGMP and/or cGTP for clinical use for more than 45 years.
  • The complexities associated with donor qualification, tissue collection and tissue processing for umbilical cord tissue are far greater under these further manufacturing standards.
  • But there were no consistent sources of cGMP collections and processing for further manufacture until BioBridge Global made its delivery.
  • BioBridge Global and its subsidiaries have been collecting birth tissue, including umbilical cords, since 2016 and umbilical cord blood for therapeutic use since 2001.